Deep partial-thickness burns exhibit ambiguous behavior, either spontaneously healing or evolving into full-thickness burns. The aim of this study was to investigate these lesions for the presence of apoptotic cells and to compare their rate with that of superficial and fullthickness burns. We used colocalization of DNA fragments (ie, terminal deoxynucleotidyl transferase Biotin-dUTP nick end labeling) and Fas ligand CD95 antibodies to calculate the apoptotic rate of superficial, deep partial-thickness and full-thickness burns in 45 patients after the thermal injury. Biopsies were collected mainly during the acute postburn phase (first week of hospitalization). Deep partial-thickness burns presented apoptotic cells, both in the dermis and in cutaneous adnexa, and showed a higher apoptotic rate than superficial and full-thickness burns (44.5% in deep partial thickness, interquartile range 6.3-90.5%; 5.6% in superficial partial thickness, interquartile range: 0 -13%; 0% for full-thickness burn; P ‫؍‬ .000243). A significant greater apoptotic rate was present in cells of deep partialthickness burns when compared with superficial and full thickness. These data would suggest that deep burns sustain an ischemic damage that forces cells to undergo apoptosis and could represent the biologic basis for their clinical evolution into full-thickness burns. 
Cutaneous thermal burns are universally classified, according to their depth, in superficial partial thickness, deep partial thickness, and full thickness. Morphologically, these degrees often show a "target-like" appearance ( Figure 1 ) with an inner area composed of necrotic tissues (full thickness), an intermediate rim of ischemic cells (deep partial thickness), and an outer rim of hyperemic zone (superficial partial thickness). 1 Clinically, they present different evolutions: although full thickness burns have no possibility of healing, superficial partial-thickness burns spontaneously heal without aesthetic damages and deep partial-thickness burns either heal spontaneously or evolve into fullthickness burns.
Diseases derived from an acute ischemia (myocardial infarctions, strokes, renal infarctions) have clinical and pathologic characteristics similar to those shown by burns. Morphologically, the classic "targetlike" appearance is present with an inner necrotic area corresponding to the zone directly fed from the closed vessel, an ischemic intermediate rim to the zone in which collateral vessels partially overcome closed vessels in feeding cells, and an outer inflammatory zone corresponding to a zone of vasodilation that spontaneously recovers after the event. Clinically, the inner necrotic area is irreversibly dead, the inflammatory perilesional area always recovers without apparent damage, and the ischemic "stunned" area recovers only if revascularized in the first few days after injury; otherwise, it irreversibly dies.
In recent years, researchers, trying to explain the peculiar postinjury clinical worsening of myocardial infarctions and strokes, focused on the ischemic "stunned" zones and found that apoptotic cells were present in these areas and that a clear correlation existed between their number (apoptotic rate) and the clinical worsening manifestedbypatients. [2] [3] [4] [5] [6] [7] Becausedeeppartial-thickness burns create an ischemic environment and often progressively worsen into full-thickness burns, we hypothesized that this could be derived from the apoptotic mechanism of death as in myocardial infarctions and strokes. 8 In the present study, we compared the apoptotic rate of deep partial-thickness burns with those of superficial partial-thickness and full-thickness to confirm that the apoptotic phenomenon is specific for the former lesions.
MATERIALS AND METHODS
This study was conducted with the approval of the Institutional Review Board of the S. Eugenio Hospital. After explanation of the experimental nature of the study and with an informed consent signed, we gathered cutaneous biopsies from burned patients during the first 7 days of hospitalization for superficial partial-thickness burns and before any escharectomy was performed for deep partial-and full-thickness burns. One biopsy was taken for each patient. We excluded from the study: 1) patients with systemic conditions likely to affect tissue oxygenation (such as primary heart or lungs disease, diabetes, hepatic or renal insufficiency) and 2) patients that refused to give the informed consent. Systemic diseases were excluded on the base of clinical and laboratory data.
We recruited all patients with superficial, deep partialthickness and full-thickness burns. For each patient, we collected one biopsy via a cutaneous punch at least 5 cm within the specific burned tissue and away from the normal skin or other burn degrees. Deep partial-thickness burns, as well as superficial and full-thickness burns, were defined on the basis of signs, symptoms, and clinical characteristics (no pain, rose or white-pearly appearance of the lesion without change of color after pressing the skin for the deep partial-thickness burns; painful, rose and with change of skin color for superficial partialthickness burns; complete skin necrosis with eschar formation for full-thickness burns; Figures 2-4) . We histologically confirmed burn degrees in every biopsy.
We recorded the age, sex, type of burn (flame vs scald), TBSA, and deep burn surface area (deep partial thickness and full thickness). Past and recent medical history, as well as pharmacologic treatments used before recovery, were obtained at the time of hospitalization. Every patient had a picture taken initially from the biopsy site. All patients had their burns medicated at recovery with antimicrobial dressings (silvercoated high-density polyethylene mesh; Acticoat, Smith and Nephew, Largo, FL) until the day of the surgery. After that, petroleum jelly gauzes were used to cover skin grafts. Supportive therapies (ie, vasoconstrictive agents, oxygenation levels, ventilation) and deaths were recorded.
Pathology and Immunohistochemistry
Specimens were immediately fixed in 10% paraformaldehyde. First histological analysis consisted of a hematoxylin and eosin stain. Subsequent immunohistochemistry analysis consisted of using terminal deoxynucletidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) using the Apoptag kit (Oncor, Gaithersburg, Maryland, MD) and in Fas ligand CD95 antibodies (CD95 FasL Ab-4 Rabbit Pab IgG; dilution 1/100 ϭ 10 g/ml; Lab Vision Corporation NeoMarkers, Fremont, California, CA), both of them according to manufacturer's instructions. Final visualization was given by means of the streptavidin-biotin system (Dako Envision) using diaminobenzidine as final chromogen.
Dermal cells were defined as apoptotic if colocalizazion of markers of DNA fragmentation (TUNEL) and FasL was evident, in accordance with the fact that high immunohistochemical expression of TUNEL is present in cells undergoing apoptosis and colocalizes with FasL positive cells. Apoptotic rate (AR) was expressed as the ratio of the number of dermal cells showing both TUNEL and FasL positivity out of the total number of nucleated cells in each field (magnification, ϫ400) calculated after counting 10 fields for each slide: a total of 150 total microscopic fields were counted for deep partial-thickness, 150 for superficial partial-thickness, and 150 for full-thickness burns.
Suitable negative and positive controls for TUNEL and FasL ligand CD95 were performed as indicated by the supplier. For TUNEL, a normal female rodent mammary gland 3 to 5 days after weaning of rat pups was used for positive control and sham staining leaving out active TdT, but including proteinase K digestion, for nonspecific incorporation of nucleotides or for nonspecific binding of the enzyme conjugate. A "stringent approach" (leaving proteinase K digestion out of the reaction) was used as control to avoid falsepositive results potentially associated with pretreatment by proteinase K. Human mucosal of small intestine was used as a control for FasL ligand CD95 Ab-4 (immunoreactivity was evident in the apoptosis of the epithelial cells). Immunohistochemistry assays and AR counts were performed by two pathologists unaware of clinical data (P.B.M. and S.G.).
Statistical Analysis
All data analysis was performed using the Statistical Package for Social Sciences Windows version 13.0 (SPSS, Chicago, IL). After checking for normality distribution, descriptive statistics of patients characteristics were expressed as mean and standard deviation (all of them had a normal distribution) whereas apoptotic rates of patients subgroups (superficial partial thickness, deep partial thickness, and full thickness) were expressed as mean and range (minimum-maximum: non-normal distribution). Descriptive statistics among groups of patients were compared with the analysis of variance. Apoptotic rates were compared with the Kruskal-Wallis test.
RESULTS

All data were collected between November 2005 and December 2005.
Patient Characteristics
We excluded from the study 18 patients (15 for associated diseases, 3 because refused informed consent) and recruited 45 patients (Table 1) . Thirty-eight patients (84.4%) were biopsied during the first week of hospitalization, seven (15.6%) gave consent later because they previously were unconscious and unable to give the informed consent (median day of biopsy, 3; range, 2-23).
There were 34 men (75.6%) and 11 women (24.4%). Twenty-six received fire burns, 19 scalded burns. One patient experienced a previous burn episode 10 years before (a biopsy was collected from the newly formed burn). Ten patients recovered in the intensive care unit and were only receiving cardiovascular and ventilatory support. Four of the patients became septic on postburn days 5 to 8, and six died. The mortality rate was 13.3% (6/45). When analyzed according to burn degrees (superficial partial thickness, deep partial thickness, and full thickness), the three subgroups were homogeneous for the variables recorded (age, sex, type of burn, TBSA, deep burn surface area, and postburn day in which biopsy was collected) and treatments received (both local and systemic; P Ͻ .05).
Immunohistochemistry Analysis
Apoptotic cells were present in biopsies collected from deep partial-thickness burns as well as from superficial partial-thickness burns. In these specimens, they were found not only in dermal fibroblasts (for which the apoptotic rate was calculated) but also in cells of cutaneous adnexa (sweat glands and hair follicles) where the apoptotic presence seemed even higher than in dermis (Figures 2 and 3) . Although in deep partial-thickness burns the apoptotic cells tended to form clusters (Figure 3) , in superficial partial-thickness burns, they were scattered throughout the specimen (Figure 2 ). Apoptotic cells were absent in full-thickness burns because only a coagulative necrosis, with complete alteration of tissues, and an aspecific uptake of apoptotic markers, without clear anatomic contours of cells, could be detected (Figure 4) .
Statistical Analysis
Statistical analysis showed that apoptotic rates were 44.5% in dermal cells of deep partial-thickness burns (range, 6.3-90.5%), 5.6% in superficial partial thickness (range, 0 -13%) and 0% in full-thickness burns (Kruskal Wallis test, P ϭ .00024; Figure 5 ).
DISCUSSION
Deep partial-thickness burns are characterized by thrombosed and not reactive blood vessels that create an ischemic zone in which dermal cells are forced to survive. This environment renders tissues particularly prone to local oxygenation status and superimposed Figure 4 . Left panel, an 88-year-old patient with full-thickness burns on the thorax after gas explosion in his house. Middle panel, histological examination using hematoxylin and eosin staining shows a coagulative necrosis (ϫ100). Right panel, analysis using terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling and FasL immunohistochemistry. Aspecific fixation of reagents (ϫ100) with no possibility to calculate an apoptotic rate.
infections. Even without these additional conditions and with the best intensive systemic and local care, the clinical behavior of these tissues often is unpredictable: sometimes they shift into superficial partialthickness burns with complete restitution ad integrum, and sometimes they evolve into full-thickness burns with necrosis and subsequent scar formation. 1 This ambiguity is not shown by superficial partialthickness and full-thickness burns, in which respectively a complete healing and a definitive eschar formation is present. To understand the cellular basis of this clinical phenomenon, we recently evaluated deep partial-thickness burns and found the presence of apoptotic cells. 8 This discovery opened new fields of research. It is well known that diseases deriving from an acute loss of oxygen supply, such as myocardial infarctions and strokes, have an intermediate "stunned" zone in which cells are functionally inactive but anatomically viable. 4 Poor local perfusion creates an ischemic environment that, if not revascularized, inevitably dies during the initial days after injury. Recently, researchers demonstrated that the apoptotic mechanism is responsible for cell deaths in this intermediate zone. [2] [3] [4] [5] [6] [7] Our confirmation of apoptotic cells in deep partialthickness burns lead us to hypothesize that cutaneous responses to thermal injury could be similar to those of ischemic diseases to the acute oxygen loss. Furthermore, a "target-like" appearance often is visible in burned patients and is similar to that present at the gross pathologic postmortem examination in myocardial infarctions and strokes (Figure 1 ). For these reasons, in the present study, we evaluated burn degrees with the working hypothesis that deep partialthickness burns, more than others, should have the greatest presence of apoptosis for their peculiar ischemic environment.
To the best of our knowledge, the present study shows for the first time that a significant loss of dermal cells in deep partial-thickness burns derives from apoptosis and that this phenomenon is specific for this burn type. In fact, the presence of a higher rate of positive cells to TUNEL and FasL immunoistochemistry than that of superficial and full-thickness burns seems to demonstrate it. TUNEL alone has been used in many works to detect apoptosis, [3] [4] [5] but we decided to contemporarily add another sensitive method, FasL CD95, to add specificity to our findings.
Our data cannot allow us to correlate AR with the evolution of deep partial-thickness burns into fullthickness burns because most patients underwent early escarectomy, after biopsy harvesting, as the gold standard treatment. However, the data may sustain the hypothesis that deep burns evolution could be related with apoptosis. The next step is to verify this hypothesis with specific studies in which small areas of deep partial-thickness burns are harvested and lesions followed clinically for 2 or 3 weeks without undergoing escharectomy. Should this hypothetic relationship (between apoptotic rate and evolution into full thickness) be confirmed, it would suggest the intriguing possibility to recover deep burned areas in patients unfit for early surgery (ie, those with unstable cardiovascular conditions) with treatments aimed at blocking this type of cell response to injuries.
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CONCLUSIONS
Our study demonstrates that deep partial-thickness burns have a significant higher apoptotic rate than superficial and full-thickness burns, confirming the hypothesis that ischemia present in these lesions jeopardizes tissue recovery by an apoptotic mechanism. Although the etiology is different, burned tissues react the same way as myocardial or nervous tissue to ischemic injury. It would also suggest that bad clinical evolutions of deep partial-thickness into full-thickness burns can be related to apoptosis. Further studies are now required to correlate it with burns clinical evolution Table 1 . 
